Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,958.6
13.1 (0.45%)

 

  • STI Straits Times Index
    2,958.6
    13.1 (0.45%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,580.6
    5.3 (0.34%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,297.5
    -93.7 (-0.32%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,573.3
    3.9 (0.11%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,635.2
    89.0 (0.31%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,109.2
    -31.0 (-0.50%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 3,223.3M
  • Value: 1,250.2M
  • Rise: 216
  • Fall: 154
  • Unch: 407

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
China Star Food0.044-0.006
China Env Res0.023+0.010
Jiutian Chemical0.105-0.001
Asian Micro0.020-0.004
Artivision Tech0.012-
The Place Hldg0.145-0.020
Samko Timber0.046+0.008
MMP Resources^0.009-0.001
Guoan Intl0.014+0.004
Oceanus^0.052+0.001

World Indices

World Indices
Name Last Change
Nasdaq 13,626.1 -9.9
HSI 29,297.5 -93.7
HSCEI 11,651.2 -44.2
Jakarta 6,109.2 -31.0
Nikkei 225 28,635.2 +89.0
SSE Comp 3,573.3 +3.9
Shanghai A 3,745.6 +4.1
Shanghai B 247.5 +1.7
KOSPI 3,122.6 -17.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ALNYLAM PHARMACEUTICALS INC ALNYLAM PHARMACEUTICALS
Updated on 26 Jan 2021 (End of trading day)
Last (USD): 170.020 Change: -5.670 High: 178.410 Remarks: -
Change (%): -3.23 Low: 169.160
Open 174.150 Yesterday's Close 175.69
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 539,596 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -7.62703 Trailing EPS (USD) e -7.66843 NAV (USD) b 10.4580
PE a - Trailing PE f - Price / NAV b 16.2574
Dividend (USD) d - Cash In Hand (USD) g 4.2753 Issued & Paid-up Shares c 116,181,000
Dividend Yield (%) d - Price / Cash In Hand g 39.768 Treasury Shares h -
Market Cap (M) 19,753.094 Enterprise Value (M) 19,291.691
Piotroski F Score 1 Exchange Code ALNY Par Value ( $ ) n.a.
52 Weeks Volatility (%) 49.56 Free Float (%) 98.7
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 06 Nov 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ALNYLAM PHARMACEUTICALS INC NASDAQ 19,753.094 - - 16.2574 -
Industry Biotechnology NASDAQ 3,232.152 506.525 - 7.7542 0.527
Local Peer AMGEN INC NASDAQ 150,548.903 19.198 20.477 13.7375 2.278
Local Peer GILEAD SCIENCES INC NASDAQ 83,610.451 15.524 65.939 4.7928 3.816
Local Peer VERTEX PHARMACEUTICAL NASDAQ 61,795.430 52.511 22.966 7.5977 -
Local Peer ILLUMINA INC NASDAQ 61,400.300 61.278 96.239 13.0639 -
Local Peer MODERNA INC NASDAQ 60,120.220 - - 21.7843 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 58,058.718 27.441 18.396 5.7339 -
Local Peer BIOGEN INC NASDAQ 41,805.123 7.099 8.225 3.8858 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 35,378.122 14.715 36.983 3.1944 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 32,676.845 - - 7.6214 -
Local Peer SEAGEN INC NASDAQ 31,128.028 - 65.893 13.7855 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 25,315.408 - - 23.2709 -
Local Peer EXACT SCIENCES CORP NASDAQ 22,429.591 - - 9.5972 -
Other Local Peers INCYTE CORPORATION (NASDAQ), 10X GENOMICS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIO-TECHNE CORP (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), FIBROGEN INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), SEER INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), EDITAS MEDICINE INC (NASDAQ), IMMUNOVANT INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), ALKERMES PLC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), VERACYTE INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALLOVIR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), NANTKWEST INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MYRIAD GENETICS INC (NASDAQ), VIELA BIO INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), REGENXBIO INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), PERSONALIS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), BIOATLA INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), NKARTA INC (NASDAQ), PRECIGEN INC (NASDAQ), CYTOKINETICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALECTOR INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), INHIBRX INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), VAXCYTE INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), OMEROS CORP (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), MERUS B V (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VAXART INC (NASDAQ), COMPUGEN (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), HUMANIGEN INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), KADMON HLDGS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CURIS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CHIMERIX INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), AFFIMED N V (NASDAQ), AGENUS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), IMMATICS N V (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ANAPTYSBIO INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AKOUOS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ATRECA INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), GERON CORP (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), ONCORUS INC (NASDAQ), BIOVIE INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), CUE BIOPHARMA INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ATHERSYS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), NEXTCURE INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), KAMADA LTD (NASDAQ), BELLUS HEALTH INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MEDICINOVA INC (NASDAQ), INMUNE BIO INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ADICET BIO INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), EVOGENE LTD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), METACRINE INC (NASDAQ), CHIASMA INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), SESEN BIO INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMV INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), OTONOMY INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), IMMUNOME INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), ORGENESIS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), COHBAR INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), SAVARA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ADVAXIS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), RECRO PHARMA INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BIOCARDIA INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), PRECIPIO INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), HISTOGEN INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), GEOVAX LABS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ)
Global Peer CSL LTD ASX 125,208.845 39.922 39.922 13.2068 1.066
Global Peer WUXI BIO HKEx 457,363.738 397.851 317.634 30.6176 -
Global Peer BEIGENE HKEx 246,812.772 - - 7.4278 -
Global Peer SINO BIOPHARM HKEx 141,291.886 46.034 55.213 3.9202 0.710
Global Peer ZAI LAB-SB HKEx 114,431.460 - - 31.7198 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,796.512 106.358 34.793 4.6317 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 20,565.136 - - 2.8127 -
Global Peer 3SBIO HKEx 18,949.820 17.163 12.621 1.6200 -
Global Peer ARCUS BIOSCIENCES INC NYSE 2,339.186 - - 4.2967 -
Other Global Peers JW THERAP-B (HKEx), MYOVANT SCIENCES LTD (NYSE), JACOBIO-B (HKEx), VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), FRONTAGE (HKEx), HAOHAI BIOTEC (HKEx), JHBP-B (HKEx), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), MESOBLAST LTD (ASX), TELIX PHARMACEUTIC (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), DPHARMA (Bursa), SQZ BIOTECHNOLOGIES CO (NYSE), KINTOR PHARMA-B (HKEx), SINOMAB BIO-B (HKEx), OPTHEA LIMITED (ASX), ASCLETIS-B (HKEx), IMUGENE LIMITED (ASX), LEE'S PHARM (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), ESSEX BIO-TECH (HKEx), 22ND CENTURY GROUP INC (NYSE American), NANOVIRICIDES INC (NYSE American), IMMUTEP LTD (ASX), NEXT SCIENCE LTD (ASX), ANTEOTECH LIMITED (ASX), IBIO INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), NEUREN PHARMACEUTICALS LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), BIONOMICS LTD (ASX), UNI-BIO GROUP (HKEx), GENETIC TECHNOLOGIES (ASX), CYNATA THERAPEUTICS LTD (ASX), LEAF RESOURCES LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), REGENT PACIFIC (HKEx), MEMPHASYS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ORAGENICS INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PATRYS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), BIOTRON (ASX), CT ENTERPRISE (HKEx), Suntar Eco-City (SGX), CONSTELLATION TECHNOLOGIES LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CONTANGO ASSET MANAGEMENT LIMITED (ASX), REGENEUS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), ADALTA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), RHINOMED LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), NANOLLOSE LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), CRYOSITE (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), HAO WEN HLDGS (HKEx), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.950
-0.56 %
10 Days --0.910
-0.53 %
20 Days -+38.980
+29.75 %
Medium Term Return 3 Months -+45.140
+36.15 %
6 Months -+19.460
+12.93 %
1 Year -+52.090
+44.17 %
Long Term Return 2 Years -+88.320
+108.10 %
3 Years -+40.040
+30.80 %
5 Years -+103.890
+157.10 %
Annualised Return Annualised --
+20.79 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 84.970 - 176.780 Change From 1 Year Low +85.050 % Change From 1 Year Low (%) +100.09
Change From 1 Year High -6.760 % Change From 1 Year High (%) -3.82
2 Years Range 65.810 - 176.780 Change From 2 Years Low +104.210 % Change From 2 Years Low (%) +158.35
Change From 2 Years High -6.760 % Change From 2 Years High (%) -3.82
5 Years Range 31.380 - 176.780 Change From 5 Years Low +138.640 % Change From 5 Years Low (%) +441.81
Change From 5 Years High -6.760 % Change From 5 Years High (%) -3.82
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
26 Jan 2021 174.150 178.410 169.160 170.020 539,596 -
25 Jan 2021 170.430 176.780 168.145 175.690 1,158,044 -
22 Jan 2021 165.780 173.200 163.900 172.380 534,945 -
21 Jan 2021 172.540 172.610 166.350 166.750 543,691 -
20 Jan 2021 169.650 173.000 167.010 170.970 1,028,018 -
19 Jan 2021 167.880 171.000 167.020 168.410 637,870 -
15 Jan 2021 165.350 171.010 165.350 166.360 711,647 -
14 Jan 2021 169.780 169.780 164.016 165.070 1,279,958 -
13 Jan 2021 165.650 175.410 163.950 170.930 2,440,830 -
12 Jan 2021 156.030 165.910 156.030 165.650 1,550,933 -
11 Jan 2021 148.560 157.390 146.420 156.630 1,316,667 -
08 Jan 2021 138.730 147.000 137.724 146.660 829,628 -
07 Jan 2021 133.620 140.000 132.030 139.400 1,072,701 -
06 Jan 2021 126.330 128.125 125.380 126.830 758,511 -
05 Jan 2021 125.560 127.700 124.000 127.450 499,662 -
04 Jan 2021 130.690 132.780 126.940 128.100 527,642 -
31 Dec 2020 131.330 132.420 127.690 129.970 338,669 -
30 Dec 2020 131.900 134.155 129.170 131.040 256,897 -
29 Dec 2020 134.560 136.910 130.000 130.560 368,145 -
28 Dec 2020 138.600 140.000 133.670 134.080 340,047 -
24 Dec 2020 138.620 140.110 136.800 137.560 150,982 -
23 Dec 2020 138.300 140.010 135.470 138.620 590,042 -
Summary
Current 2 Weeks
(12 Jan 2021 to 26 Jan 2021)
156.030 178.410 156.030 170.020 10,425,532 -
Previous 2 Weeks
(28 Dec 2020 to 11 Jan 2021)
138.600 178.410 133.670 156.630 6,308,569 -
4 Weeks from
(27 Nov 2020 to 24 Dec 2020)
125.880 178.410 125.640 137.560 9,716,339 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.